Our findings are consistent with the literature, demonstrating reduced CSF α-synuclein in PD patients in comparison to healthy controls [44,45], but we could not detect differences between PD subjects with normal and reduced cognitive scores. This evidence concerns the gene SNCA and Parkinson disease.